Skip to content

Clinical trials

Phase 4 Hypertension trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 4 Country / region: Taiwan Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20041
20052
20063
20074
20092
20101
20121
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital4
Sanofi4
Boehringer Ingelheim3
Novartis2
Chang Gung Memorial Hospital1
Eisai Inc.1
GlaxoSmithKline1
Novartis Pharmaceuticals1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
TSH Biopharm Corporation Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension20
Diabetes Mellitus, Type 22
Diabetic Nephropathies2
Albuminuria1
Edema1
Essential Hypertension1
Heart Diseases1
Hyperaldosteronism1
Hypercholesterolemia1
Sleep Apnea, Obstructive1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.